Oliver Hasler, executive chairman of PYX Resources, presents 1H24 Results. Watch the interview here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: Schlum, 12 Sep 2024 12:30
Last post: HOMER1234, 12 Sep 2024 13:59
I agree with John. Hopefully, we won't have any more lazy placements from the company.
I think longer terms holders are hesitant to post anything positive due to past let downs....
I do however feel somewhat optimistic that N4 are close to rewarding shareholders.
If the SRI work confirms that the siRNA can retain its functionality in its target cell, then we are surely well placed for a company to take a keen interest.
At £2m market cap N4P offers tremendous upside.
Started: wully29, 9 Sep 2024 14:02
Last post: wully29, 9 Sep 2024 14:02
Maybe another placing on the way to pay for his wages ?? 🤔
https://abou****/michael.palfreyman
interesting gentleman, with huge clout and experience. great appointment. let's hope it bears fruit.
Started: BasilAlderman, 9 Sep 2024 07:21
Last post: DCraig, 9 Sep 2024 09:54
I'd be interested to see what market value Dr Palfreyman would place on the company.
$100m seems a very large valuation however unicorns do seem to exist in this market.
This is huge news, probably the most important piece of news this year. Finally the company has someone in its ranks with the capability and network to deliver it's exit strategy. It felt like previously, it would have to happen by chance, as I have no faith in anyone else in the company delivering this. However, this could now be a game changer. GLA
Let’s hope he can sell N4p for $100m.
Exactly, Dr Palfreyman selling his pharma businesses to Roche for US$230 million his other pharma business for US$180 million is very encouraging. We clearly have a serious player in our boardroom to deliver an exit strategy for N4P moving forwards ...
Good luck, Brighty
Looks to be a decent and timely appointment.
Started: DCraig, 27 Aug 2024 13:38
Last post: Trucks21, 29 Aug 2024 17:46
It's been a long, hard, painful slog for many of us small shareholders. Surely the company realises this. And hopefully, they are working hard to give us some hope of recouping our losses, which were on their behalf. It's been a huge risk for all of us. But we hold onto the belief that the products will eventually become successful.
An announcement re a large pharma showing interest, cannot come soon enough.
Yes, but it's been going on for a while.
All £3 grands worth???
This is just the rest of the last placement at 5p being sold.
Started: oogleflugal, 23 Aug 2024 10:45
Last post: sightwatcher, 23 Aug 2024 20:12
It is a matter of time when this goes into administration, We lost of our money and it is a lesson not to invest in small AIM ventures.
Change of auditor. Obviously the outgoing one just felt inadequate to cope with the tsunami of revenue about to be unleashed upon Not For Pussies
Last post: msuk.int, 21 Aug 2024 07:24
Chart still in tact.0.65 to break for a rise.0.90 is first PT
Started: Isthisawinner, 20 Aug 2024 07:07
Last post: Isthisawinner, 20 Aug 2024 09:04
Agree, pieces coming together now, it the latest test confirms a satisfactory outcome, then we're on a a different playing field and hopefully the sp will reflect that soon..gla
Wow... a price movement "AFTER" an rns... that's a new one!
Even a 200% increase would leave me with a bit of loose change…. The company has been devalued so much that I cannot get excited by it anymore
It certainly opens the door for an offer from big pharma and we all know it does happen
This is exciting news. To be joint marketing this breakthrough with the well connected and regarded, Californian organisation, is meaningful indeed,for a £2million market cap company such as N4P.
Last post: msuk.int, 16 Aug 2024 08:26
It wants to go above .65....needs buy volume
Let's hope so. Thanks.
Had c 30 days of consolidation u can see from sideways move ,from there it has broken up above then another c 10 days ,we can see now we have an upward bias ,we have now few long green candles where buyers have come in ,the break of 0.70 will see my target of near 1.00 also from chart u can see the curve outlining the pattern ,
For those who don't understand charts, could you translate please?
Last post: HOMER1234, 9 Aug 2024 16:30
Another raise is out of the question at the moment. No need.
But he did backtrack on his last pledge so never say never.
He might buy another company that needs money and can baffle us all with bull shi
Anyone think no that since, yet another raise in funds that good old Nige has gone quiet…. Typical N4.
He’s probably on holiday as I type, maybe Luke Cairns can update us and earn his wage….
Started: DCraig, 9 Aug 2024 09:04
Last post: DCraig, 9 Aug 2024 09:04
Seems to be a bit more meat on the bone with the trades coming through.
Last post: msuk.int, 9 Aug 2024 07:44
Poss target to the weekly 50 ema
Looks good with price above the 50 day moving avarage
Started: Karlvonwise, 31 Jul 2024 08:17
Last post: DCraig, 31 Jul 2024 14:13
It does move very drastically with good news. the issue is of late we have only had news that has moved the price further and further down.
still holding, still hoping things will turn around.
Speculation, but with news this will move.
Potential movement today ?
Started: Karlvonwise, 30 Jul 2024 19:49
Last post: Karlvonwise, 30 Jul 2024 19:49
The buys outweigh the sells but we still in the red ???
Started: Trucks21, 29 Jul 2024 12:45
Last post: HOMER1234, 29 Jul 2024 16:48
Also, people have been able to sell the placement for a profit.
We've seen this plenty of times before. a few people will have taken some healthy profits today. can't say i blame them..
Movement without news rarely sustains with this one.
not time to start holding our breath just yet.
Well, the rise was short lived...9% now, might end flat for the day..
Fda Approval not due till September so can’t be that. Could be negotiating a partnership or licensing deal. Could be market makers playing silly buggers. Not exactly big trades
Two delivery systems that are able to get the correct response when delivering siRNA, with an attractive partner (SRI) pushing one of the novel systems forward.
All this for £2m mcap..crazy.
Still high risk obviously but the upside can’t be ignored if one of these systems gets a deal.
Started: Waynesmith, 29 Jul 2024 13:30
Last post: Drutor, 29 Jul 2024 13:33
Bwekfast
HMMMM PREY TELL
Started: KnockOutthePin, 26 Jul 2024 11:15
Last post: Karlvonwise, 29 Jul 2024 10:17
Dan55
I tend to agree with you, Dan, but Nigel has made a smart move by partnering with SRI International. Let's face it—Nigel can now relax while SRI handles all the commercialization efforts.
Price: 0.45
No Opinion
RE: Is anything going on?26 Jul 2024 11:35
Such small buys my guess is someone trying to get the price up then sell out once the price raises but markets not falling for it . Can’t see any news coming in as Nigel got his money from the placing until he runs out of
The mkt caps of many small U.K. biotech companies are such, that opportunistic takeover by US corporations may be the saddish? end to a lot of great research work.
Still moving higher. A decent RNS would be just the ticket.
Such small buys my guess is someone trying to get the price up then sell out once the price raises but markets not falling for it . Can’t see any news coming in as Nigel got his money from the placing until he runs out of cash same pattern last 2-3 years.
Every day seemingly it pops into my top risers at 7-11% and .5p and big spread of 20% with quite a good number of trades. Anyone got any idea if there is actually something happening or expected? Like most here, massively under water so just wondered otherwise back in bottom drawer.
Started: Gaz_Marsden, 26 Jul 2024 19:24
Last post: Gaz_Marsden, 26 Jul 2024 19:24
Is there a telegram chat / channel? Anyone advise how to access?
Started: Isthisawinner, 26 Jul 2024 16:38
Last post: Karlvonwise, 26 Jul 2024 19:11
As long as the RNS is not another placing .......
I was waiting for those two late trades to pop up. Hence price not moved
Hoping for a whammy of an RNS on Monday, need it, I'm so under water here...lol...gla
Started: HOMER1234, 25 Jul 2024 12:32
Last post: Karlvonwise, 25 Jul 2024 18:30
Totally confused, I bought more at0.487 but not showing
That's impossible with that spread. The selling price is 0.40/42 and the buy is 0.48/50.
Day traders making small amounts on the spread.
Every day we seem to be getting a load of trades with no movement.
Again today 100 trades.
Started: DCraig, 18 Jul 2024 08:10
Last post: mannnan, 19 Jul 2024 14:24
Rajah. Going down again
In my view , we should give up any hope and there is not any ray of hope to mitigate our losses.
Quite a spread the moment.
I am amazed this has not moved up with all the trades at full ask.
Just trying to encourage small day trades it seems.
0.5p - 0.4p - 0.
Last post: Trucks21, 12 Jul 2024 14:11
Unfortunately all very small trades. We're all clinging on for some good news here.
A lot of blue trades in there today. i know we see these days regularly and there doesn't seem to be for any rhyme or reason. fingers crossed there's something behind this one.
Started: OldsCool, 11 Jul 2024 08:47
Last post: mannnan, 11 Jul 2024 15:42
Hello. Rajah. Nothing is coming.rajah
1111 Trade, news incoming?
Started: Bufflehead1992, 25 Jun 2024 10:09
Last post: oogleflugal, 3 Jul 2024 09:28
FDA approval followed by first clinical trial early 2025 is inching forward progress. No doubt it will fall back in the intervening 3 months before approval.
This needs committed support by a commercial partner and dedicated scientists who will try drive the financial and clinical development process forward
Small PIs will pay Nigel’s salary over the next decade until his retirement but much more is needed
I see Nigel edited a reply to a question about authentication in September. Maybe there will be something new. He seems quite keen to get investors to engage to help him explain better how N4p is proceeding and for us to better understand the process of development which has been quite fragmented
Ahh, this was the message:
N4 Pharma will be hosting a pre-recorded presentation relating to the Company's newly released corporate presentation, announced on 11 June 2024.
The video presentation will be available for viewing from 10am BST on Wednesday 26th of June on our investor hub.
Yes maybe, someone on telegram said they were doing a pre recorded video, talking through the last presenation, that would be released today…. Maybe they got it wrong.